Description: Calmare Therapeutics Incorporated, the Calmare Pain Mitigation Therapy company, researches, develops and commercializes chronic, neuropathic pain and wound affliction devices. Our flagship medical device - the Calmare Pain Therapy Device (the Calmare Device) is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. The Company holds a U.S. Food & Drug Administration 510k clearance designation on its flagship device, which grants it the exclusive right to sell, market, research and develop the medical device in the United States. Calmare Devices are commercially sold to medical practices throughout the world. They are also found in U.S. military hospitals, clinics and on installations via CTI's General Services Administration (GSA) military contract
Home Page: www.calmaretherapeutics.com
1375 Kings Highway East
Fairfield,
CT
06824
United States
Phone:
203-368-6044
Officers
| Name | Title |
|---|---|
| Mr. Conrad F. Mir | Pres, CEO & Director |
| Mr. Thomas Philip Richtarich M.B.A. | Chief Financial Officer |
| Ms. Donna J. Mays | Mang. of Admin. Services |
| Dr. Stephen J. D'Amato | Chief Medical Officer & Member of Medical Advisory Board |
| Mr. William Lipford | Division Head of Product Sales |
Exchange: OTCCE
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.815 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 7 |